Iman Jilani

2.2k total citations
54 papers, 1.6k citations indexed

About

Iman Jilani is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Iman Jilani has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 30 papers in Genetics and 15 papers in Molecular Biology. Recurrent topics in Iman Jilani's work include Chronic Lymphocytic Leukemia Research (24 papers), Acute Myeloid Leukemia Research (22 papers) and Lymphoma Diagnosis and Treatment (14 papers). Iman Jilani is often cited by papers focused on Chronic Lymphocytic Leukemia Research (24 papers), Acute Myeloid Leukemia Research (22 papers) and Lymphoma Diagnosis and Treatment (14 papers). Iman Jilani collaborates with scholars based in United States, Germany and Italy. Iman Jilani's co-authors include Maher Albitar, Hagop M. Kantarjian, Michael J. Keating, Francis J. Giles, Kim‐Anh Do, Susan O’Brien, Yang O. Huh, Deborah A. Thomas, Elihu H. Estey and Susan Lerner and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Iman Jilani

52 papers receiving 1.6k citations

Peers

Iman Jilani
Sílvia Marcé Spain
Antonella Zucchetto Italy
Ilaria Del Giudice Italy
Enrico Tiacci Italy
Ellen Schlette United States
Riccardo Bomben Italy
Lourdes Florensa Spain
Amber Gordon United States
Sarah E. M. Herman United States
Jane Starczynski United Kingdom
Sílvia Marcé Spain
Iman Jilani
Citations per year, relative to Iman Jilani Iman Jilani (= 1×) peers Sílvia Marcé

Countries citing papers authored by Iman Jilani

Since Specialization
Citations

This map shows the geographic impact of Iman Jilani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iman Jilani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iman Jilani more than expected).

Fields of papers citing papers by Iman Jilani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iman Jilani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iman Jilani. The network helps show where Iman Jilani may publish in the future.

Co-authorship network of co-authors of Iman Jilani

This figure shows the co-authorship network connecting the top 25 collaborators of Iman Jilani. A scholar is included among the top collaborators of Iman Jilani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iman Jilani. Iman Jilani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albitar, Maher, Steven J. Potts, Francis J. Giles, et al.. (2009). Proteomics-based prediction of clinical response in acute myeloid leukemia. Experimental Hematology. 37(7). 784–790. 11 indexed citations
2.
Jilani, Iman, B. Nebiyou Bekele, Michael J. Keating, et al.. (2009). Soluble syndecan‐1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia. International Journal of Laboratory Hematology. 31(1). 97–105. 18 indexed citations
3.
Jilani, Iman, Hagop M. Kantarjian, M. Gorre, et al.. (2008). An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation. Leukemia Research. 32(6). 936–943. 12 indexed citations
4.
Ma, Wanlong, Hagop M. Kantarjian, Susan O’Brien, et al.. (2008). Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia. Cancer. 112(6). 1306–1312. 28 indexed citations
5.
Jilani, Iman, M. Gorre, Hagop M. Kantarjian, et al.. (2007). A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry. Leukemia & lymphoma. 48(11). 2189–2195. 20 indexed citations
6.
Chan, Huai En Huang, Iman Jilani, Richard L. Chang, & Maher Albitar. (2007). Detection of Chromosome Translocations by Bead-Based Flow Cytometry. Methods in molecular biology. 378. 167–174. 4 indexed citations
7.
8.
Albitar, Maher, Steven J. Potts, Francis J. Giles, et al.. (2006). Proteomic‐based prediction of clinical behavior in adult acute lymphoblastic leukemia. Cancer. 106(7). 1587–1594. 25 indexed citations
9.
Sheikholeslami, Mohammad, Iman Jilani, Michael J. Keating, et al.. (2006). Variations in the detection of ZAP‐70 in chronic lymphocytic leukemia: Comparison with IgVH mutation analysis. Cytometry Part B Clinical Cytometry. 70B(4). 270–275. 18 indexed citations
10.
Albitar, Maher, Julie M. Vose, Marcella M. Johnson, et al.. (2006). Clinical relevance of soluble HLA-I and β2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease. Leukemia Research. 31(2). 139–145. 26 indexed citations
11.
Ravandi, Farhad, Iman Jilani, Elihu H. Estey, et al.. (2006). Soluble phosphorylated fms-like tyrosine kinase. Leukemia Research. 31(6). 791–797. 8 indexed citations
12.
Kantarjian, H, Iman Jilani, M. Gorre, et al.. (2006). Heterogeneity in detecting Abl kinase mutations and better sensitivity using circulating plasma RNA. Leukemia. 20(11). 1989–1991. 11 indexed citations
13.
Albitar, Maher, Kim‐Anh Do, Marcella M. Johnson, et al.. (2004). Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti‐CD52 antibodies. Cancer. 101(5). 999–1008. 59 indexed citations
14.
Jilani, Iman, Michael J. Keating, Francis J. Giles, et al.. (2004). Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay. Leukemia Research. 28(12). 1255–1262. 25 indexed citations
15.
16.
Ahmed, Maha, Francis J. Giles, Donna M. Weber, et al.. (2003). Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma. European Journal Of Haematology. 71(3). 174–178. 11 indexed citations
17.
Jilani, Iman, Elihu H. Estey, M. A. Caligiuri, et al.. (2003). Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA. Leukemia. 17(1). 114–119. 28 indexed citations
18.
Huh, YO, Iman Jilani, Elihu H. Estey, et al.. (2002). More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia. Leukemia. 16(11). 2249–2252. 20 indexed citations
19.
Jilani, Iman, Elihu H. Estey, Yang O. Huh, et al.. (2002). Differences in CD33 Intensity Between Various Myeloid Neoplasms. American Journal of Clinical Pathology. 118(4). 560–566. 94 indexed citations
20.
Huh, Yang O., et al.. (2001). Higher Levels of Surface CD20 Expression on Circulating Lymphocytes Compared With Bone Marrow and Lymph Nodes in B-Cell Chronic Lymphocytic Leukemia. American Journal of Clinical Pathology. 116(3). 437–443. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sílvia Marcé Breakdown of academic impact, for papers by Antonella Zucchetto Breakdown of academic impact, for papers by Ilaria Del Giudice Breakdown of academic impact, for papers by Enrico Tiacci Breakdown of academic impact, for papers by Ellen Schlette Breakdown of academic impact, for papers by Riccardo Bomben Breakdown of academic impact, for papers by Lourdes Florensa Breakdown of academic impact, for papers by Amber Gordon Breakdown of academic impact, for papers by Sarah E. M. Herman Breakdown of academic impact, for papers by Jane Starczynski
Rankless by CCL
2026